Why a pause on AstraZeneca’s coronavirus vaccine trial isn’t entirely bad news

While it might be a setback, the researchers are ultimately being ‘very careful,’ according to one Canadian expert.

This entry was posted in Main. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *